A loss of p53 function, either through direct mutations in the p53 gene or indirect alterations in p53 regulatory networks, is frequently observed in human cancer [3] and is associated with a high rate of genomic instability, rapid tumor progression, resistance to anti-cancer therapy and increased angiogenesis [4,5]. This evidence concerns the gene TP53 and cancer.